Margaret Ancona - 25 Feb 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Ms. Ancona's title is SVP Enterprise Transformation and Program Management Office.
Signature
By: Nathan A. Smith For: Margaret Ancona
Issuer symbol
MYGN
Transactions as of
25 Feb 2022
Net transactions value
-$64,046
Form type
4
Filing time
28 Feb 2022, 15:58:21 UTC
Next filing
23 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Tax liability $64,046 -2,594 -8.6% $24.69 27,406 25 Feb 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person on February 18, 2021. The restricted stock units granted on February 18, 2021 represent a contingent right to receive one share of the Company's common stock and vested 25% on February 25, 2022 and vests 25% on February 25, 2023, 25% on February 25, 2024, and 25% on February 25, 2025. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on February 25, 2022.

Remarks:

Ms. Ancona's title is SVP Enterprise Transformation and Program Management Office.